Three Johns Hopkins BME-associated medical technology companies have been selected by the Maryland Technology Development Corporation (TEDCO) Life Science Investment Fund for financial investment. TEDCO’s Life Science Investment Fund is specifically designed for companies that are beyond the technology validation stage and further along in product development. They invest up to $200,000 to support milestone-based medical products advance more quickly and efficiently toward commercialization.
Bina48 is a robotic head that looks and speaks like a person—it moves its lips and runs conversational software. Although the robot isn’t alive, it’s hard to say there is no life at all in Bina48. In conversation, it sometimes says surprising things. Google’s director of engineering, Ray Kurzweil, says it’s “wonderfully suggestive” of a time when computers really will think and feel.
The University of Virginia’s College at Wise and the MACH37 Cyber Accelerator at the Center for Innovative Technology announced a new partnership Friday that aims to create cybersecurity employment and education opportunities in Southwest Virginia.
Roche, the Swiss pharmaceutical company, has warned that the UK risks losing its lead in medical research after leaving the European Union. The Swiss group called for Britain to move quickly to replace European regulations with rules that give patients access to innovative treatments or else risk delays in developing crucial medicines.
WellDoc’s $29.5 million funding round made a splash earlier this year. A Samsung-led initial close of $22 million was only bolstered by another $7.5 million and a new partnership with Johnson & Johnson.
Following the deals, the company sought out executives with healthcare business experience, said CEO Kevin McRaith. Execs hired in the first half of 2016 include:
The U.S. Small Business Administration released its highly anticipated Small Business Innovation Research (SBIR) online tutorials to help small businesses navigate the SBIR program. The site provides users with a mobile-compatible site to learn about the program through a combination of videos and text. This platform will provide accessible program information and training resources to underrepresented areas. There is no registration or fee required and the courses are open to all.
In a partnership between Cray and Deloitte Advisory Cyber Risk Services, the two bring subscription-based supercomputer power to security analytics capabilities.
The challenges of modern cyber-security are complex, so complex that a supercomputer can make a big difference. That’s the hope of supercomputer vendor Cray and its partner Deloitte Advisory Cyber Risk Services.
Martine Rothblatt has made no secret of her goal to move beyond the pharmaceutical business model that made her first foray into the biotech world — United Therapeutics Corp. (NASDAQ: UTHR) — a striking success.
The goose that laid the biotech patent golden egg is in trouble with the U.S. Supreme Court. Ironically, it was the Supreme Court that helped spur the industry with the watershed Charkrabarty ruling in 1980. But what has been giveth, can also be taken away. Beginning with the 2013 Myriad decision, the Supreme Court has stripped back eligible subject matter for so-called “products of nature,” raising doubts regarding whether any significant patent protection is left for biotechnology inventions. The trend continues as recently as June 27, 2016, when the Supreme Court let the Federal Circuit decision in Sequenom stand, resulting in claims directed to noninvasive prenatal screening of fetal DNA remaining a patent-ineligible subject.
New GSK PARADE (patient rheumatoid arthritis data from the real world) app promises to ‘learn from real patients’.
Glaxo Smith Kline has released an app paired with a patient study developed to provide the pharmaceutical company with a wealth of information on how people cope with rheumatoid arthritis and inform new drug development.
